4D PHARMA PLC's ticker is LBPSW and the CUSIP is 35085K117.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -95.0% | 40,178 | -30.9% | 0.00% | – |
Q1 2022 | $20,000 | -47.4% | 58,122 | -13.5% | 0.00% | – |
Q4 2021 | $38,000 | -17.4% | 67,158 | 0.0% | 0.00% | – |
Q3 2021 | $46,000 | -29.2% | 67,158 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $65,000 | -11.0% | 67,158 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $73,000 | – | 67,158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BOOTHBAY FUND MANAGEMENT, LLC | 27,625 | $170,000 | 0.01% |
Yakira Capital Management, Inc. | 47,326 | $33,000 | 0.01% |
AQR Arbitrage LLC | 77,566 | $54,000 | 0.00% |
HGC Investment Management Inc. | 5,072 | $4,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,959 | $8,000 | 0.00% |
HRT FINANCIAL LP | 67,158 | $46,000 | 0.00% |